Title of the Review:
External Peer Review (Letter) of Safety of CBD in Humans - A Literature Review conducted on publicly available data through [December 12, 2019]

Tentative Assessment:
Influential Scientific Information

Agency Contact:
April Alexandrow

Office or Center:
Office of the Commissioner, Office of Clinical Policy & Programs (OCPP)

Subject of the Review:
Cannabidiol (CBD)

Purpose of the Review:
Conduct an expert peer review

Type of Review:
Individual Reviews (Letter Review)

Timing of Review:
Within approximately 30 – 90 days after posting of this peer review plan

Number of Reviewers:
4-10

Primary Disciplines:
At least one expert in each of the following disciplines: biology and life sciences; pharmacology; toxicology; epidemiology; and medical or clinical

Types of Expertise of Reviewers:  

Reviewers Selected by:
Designated Outside Organization

Opportunities for the Public to Comment:
No

If yes, briefly state how and when will these opportunities be provided:

Peer Reviewers Provided with Public Comments:
No